Aliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression

Evaluation Of Possible Antifibrotic Effect Of Cholecalciferol, Calci-Potriol, Aliskiren, Ramipril And Eprosartan On Carbon Tetrachloride Induced Liver Fibrosis In Albino Rats

Telmisartan inhibits the non-canonical TGF-β/JAK2/STAT3 signaling pathway and prevents carbon tetrachloride-induced liver fibrosis in rats

NATURALLY DERIVED COMPOUNDS USED FOR PREVENTION OR REGRESSION OF EXPERIMENTALLY INDUCED LIVER FIBROSIS

EMPAGLIFLOZIN MITIGATES ISCHEMIA/REPERFUSION-INDUCED LIVER INJURY IN RATS: MODULATION OF NF-ΚB, SMAD-4, VEGF, AND FIBRINOGEN PROTEIN EXPRESSIONS

OMEPRAZOLE ACTIVATES PROFIBROTIC GENES EXPRESSION IN RAT KIDNEY: IMPLICATION OF TGF-β/SMAD AND ERK1/2 SIGNALING PATHWAYS

Invasive and Non-Invasive Evaluation of antifibrotic effect of Losartan on Experimentally Induced Liver Fibrosis: A Biochemical and Histological Study

The Ameliorative Potential of Alda-1 on Experimentally Induced Liver Fibrosis in Adult Male Mice. A Histological, Immunohistochemical and Biochemical Study

Aleglitazar treats non-alcoholic steatohepatitis in mice through PPAR dependent pathway

Therapeutic Impact of Telmisartan Against The Thioacetamide Induced Hepatic Fibrosis In Rats